CELG.RT
Bristol-Myers Squibb Company Contingent Value RightsCELG.RT
CELG.RT
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
24% more capital invested
Capital invested by funds: $5.2M [Q3] → $6.42M (+$1.22M) [Q4]
0.02% more ownership
Funds ownership: 0.03% [Q3] → 0.05% (+0.02%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
5% less funds holding
Funds holding: 21 [Q3] → 20 (-1) [Q4]
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Research analyst outlook
We haven’t received any recent analyst ratings for CELG.RT.
Financial journalist opinion
We haven’t received any recent news articles for CELG.RT.
Charts implemented using Lightweight Charts™